Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
3.990
+0.100 (2.57%)
At close: Jul 31, 2026, 4:00 PM EDT
3.900
-0.090 (-2.26%)
After-hours: Jul 31, 2026, 6:26 PM EDT
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $7.67 million as of July 31, 2026. Its market cap has decreased by -31.16% in one year.
Market Cap
7.67M
Enterprise Value
7.08M
1-Year Change
-31.16%
Ranking
Category
Stock Price
$3.99
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $7.67M, a decrease of -98.89%. That is a compound annual growth rate of -55.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 7.67M | -26.95% |
| Dec 31, 2025 | 10.50M | -48.75% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 8.80M |
| CNS Pharmaceuticals | 8.50M |
| Aspire Biopharma Holdings | 8.44M |
| Immuron | 8.25M |
| Niki BioSolutions | 8.04M |
| AEON Biopharma | 7.71M |
| Aprea Therapeutics | 7.68M |
| MetaVia | 7.33M |